ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,998.74
-0.38%
US Tech 100
20,240.00
-0.65%
Dow Jones
44,722.06
-0.31%
Brent Oil
72.675
0.39%
Bitcoin
95,584.52
-0.41%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Enzo Biochem Inc (ENZ)

  7. Enzo Biochem Inc (ENZ) News

ENZ

Enzo Biochem (ENZ)

Enzo Biochem Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:ENZ
DateTimeSourceHeadlineSymbolCompany
11/27/20244:15PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNYSE:ENZEnzo Biochem Inc
11/25/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ENZEnzo Biochem Inc
10/29/20247:59PMGlobeNewswire Inc.Enzo Biochem Reports Fourth Quarter and Fiscal Year 2024 Results and Announces Cash DividendNYSE:ENZEnzo Biochem Inc
10/29/20245:04PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:ENZEnzo Biochem Inc
09/24/20245:19PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ENZEnzo Biochem Inc
08/14/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ENZEnzo Biochem Inc
08/02/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ENZEnzo Biochem Inc
07/25/20245:23PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ENZEnzo Biochem Inc
07/25/20245:22PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ENZEnzo Biochem Inc
07/24/20247:50PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ENZEnzo Biochem Inc
06/13/20244:20PMGlobeNewswire Inc.Enzo Biochem Reports Third Quarter Fiscal 2024 Results and Provides Business UpdateNYSE:ENZEnzo Biochem Inc
06/13/20244:15PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:ENZEnzo Biochem Inc
05/24/20244:46PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ENZEnzo Biochem Inc
05/24/20244:44PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ENZEnzo Biochem Inc
03/13/20244:26PMGlobeNewswire Inc.Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business UpdateNYSE:ENZEnzo Biochem Inc
02/27/20247:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ENZEnzo Biochem Inc
02/27/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ENZEnzo Biochem Inc
02/27/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ENZEnzo Biochem Inc
02/14/202410:23AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:ENZEnzo Biochem Inc
02/13/20249:35AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:ENZEnzo Biochem Inc
02/02/20249:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ENZEnzo Biochem Inc
02/02/20249:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ENZEnzo Biochem Inc
02/02/20249:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ENZEnzo Biochem Inc
02/01/20248:33AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ENZEnzo Biochem Inc
12/21/20234:48PMEdgar (US Regulatory)Form DEFR14A - Revised definitive proxy soliciting materialsNYSE:ENZEnzo Biochem Inc
12/21/20234:15PMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNYSE:ENZEnzo Biochem Inc
12/15/20234:15PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:ENZEnzo Biochem Inc
12/15/20234:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ENZEnzo Biochem Inc
11/28/20235:16PMEdgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NYSE:ENZEnzo Biochem Inc
11/03/20235:07PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:ENZEnzo Biochem Inc
 Showing the most relevant articles for your search:NYSE:ENZ

Your Recent History

USOTC
SANP
Santo Mining (CE)
USOTC
ERHE
ERHC Energy (CE)
NYSE
IONQ
IonQ
NASDAQ
AMRN
Amarin
USOTC
NBRI
North Bay Resources (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
NLST
Netlist (QB)
USOTC
BIEL
Bioelectronics (PK)
NASDAQ
COOP
Mr Cooper
NASDAQ
AVXL
Anavex Life Sciences
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
SPZI
Spooz (PK)
USOTC
GDVM
Global Developments (PK)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
ELTP
Elite Pharmaceuticals (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for Ultimate Trader

1 year 40%, 2 years 50% and *3 years 60%

*Across 3 years $3395.52 only $1358.21